Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
48.89%
↑ 699% vs avg
Percentile
P100
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-8.16%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 48.89% |
| Q2 2025 | -22.62% |
| Q1 2025 | 41.75% |
| Q4 2024 | 43.77% |
| Q3 2024 | -151.36% |
| Q2 2024 | 34.82% |
| Q1 2024 | 17.78% |
| Q4 2023 | 19.67% |
| Q3 2023 | -50.46% |
| Q2 2023 | 35.99% |
| Q1 2023 | -10.87% |
| Q4 2022 | 11.41% |
| Q3 2022 | -47.34% |
| Q2 2022 | 23.69% |
| Q1 2022 | 21.51% |
| Q4 2021 | -8.54% |
| Q3 2021 | 5.51% |
| Q2 2021 | -98.39% |
| Q1 2021 | -107.81% |
| Q4 2020 | 31.42% |
| Q3 2020 | -9.13% |
| Q2 2020 | -17.45% |
| Q1 2020 | 0.00% |